azacitidine has been researched along with Dyspnea in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busija, L; Kenealy, M; McQuilten, ZK; Seymour, JF; Stanworth, S; Weinkove, R; Wood, EM | 1 |
1 other study(ies) available for azacitidine and Dyspnea
| Article | Year |
|---|---|
Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Dyspnea; Fatigue; Hemoglobins; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Quality of Life | 2022 |